Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCR

Leuk Lymphoma. 2017 Jul;58(7):1767-1769. doi: 10.1080/10428194.2016.1262033. Epub 2016 Nov 30.

Authors

Ivar O Kommers^{1

2}, Paul A Bartley¹, Bradley Budgen¹, Sue Latham¹, Ashanka Beligaswatte¹, Shane G Supple³, Alberto Catalano³, Harry J Iland^{3

4}, Alexander A Morley¹, David M Ross^{1

5}

Affiliations

¹ a Department of Clinical and Molecular Medicine , Flinders University and Medical Centre , Adelaide , Australia.
² b VU University Medical Center , Amsterdam , The Netherlands.
³ c Institute of Haematology , Royal Prince Alfred Hospital , Sydney , Australia.
⁴ d Sydney Medical School , University of Sydney , Sydney , Australia.
⁵ e School of Medicine, University of Adelaide , Adelaide , Australia.

PMID: 27899039
DOI: 10.1080/10428194.2016.1262033

No abstract available

Publication types

Letter

MeSH terms

Biomarkers, Tumor*
Bone Marrow / pathology
Bone Marrow Cells / metabolism
Bone Marrow Cells / pathology
Humans
Leukemia, Promyelocytic, Acute / diagnosis*
Leukemia, Promyelocytic, Acute / genetics*
Oncogene Proteins, Fusion / genetics*
Real-Time Polymerase Chain Reaction
Sensitivity and Specificity

Substances

Biomarkers, Tumor
Oncogene Proteins, Fusion
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein